Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

2.50
Hdl Handle:
http://hdl.handle.net/10033/621149
Title:
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Authors:
Felgner, Sebastian; Kocijancic, Dino; Frahm, Michael; Heise, Ulrike; Rohde, Manfred; Zimmermann, Kurt; Falk, Christine; Erhardt, Marc ( 0000-0001-6292-619X ) ; Weiss, Siegfried
Affiliation:
Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr.7, 38124 Braunschweig, Germany.
Citation:
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy 2017:e1382791 OncoImmunology
Journal:
OncoImmunology
Issue Date:
29-Sep-2017
URI:
http://hdl.handle.net/10033/621149
DOI:
10.1080/2162402X.2017.1382791
Additional Links:
https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1382791
Type:
Article
ISSN:
2162-402X
Appears in Collections:
publications of the research group molecular Immunology (MOLI); publications of the junior research group infection biology of Salmonella (IBIS); publications of the central unit for microscopy (ZEIM)

Full metadata record

DC FieldValue Language
dc.contributor.authorFelgner, Sebastianen
dc.contributor.authorKocijancic, Dinoen
dc.contributor.authorFrahm, Michaelen
dc.contributor.authorHeise, Ulrikeen
dc.contributor.authorRohde, Manfreden
dc.contributor.authorZimmermann, Kurten
dc.contributor.authorFalk, Christineen
dc.contributor.authorErhardt, Marcen
dc.contributor.authorWeiss, Siegfrieden
dc.date.accessioned2017-11-01T12:17:44Z-
dc.date.available2017-11-01T12:17:44Z-
dc.date.issued2017-09-29-
dc.identifier.citationEngineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy 2017:e1382791 OncoImmunologyen
dc.identifier.issn2162-402X-
dc.identifier.doi10.1080/2162402X.2017.1382791-
dc.identifier.urihttp://hdl.handle.net/10033/621149-
dc.relation.urlhttps://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1382791en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.titleEngineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
dc.typeArticleen
dc.contributor.departmentHelmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr.7, 38124 Braunschweig, Germany.en
dc.identifier.journalOncoImmunologyen
dc.contributor.institutionDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionMouse-Pathology Service Unit, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionCentral Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionSymbio Gruppe GmbH & Co KG, Herborn, Lower Saxony, Germany-
dc.contributor.institutionInstitute of Transplant Immunology, Medical School Hannover, Hannover, Hessia, Germany-
dc.contributor.institutionInfection Biology of Salmonella, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
dc.contributor.institutionDepartment of Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Lower Saxony, Germany-
This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.